Want to see AU:GLH full AI Analyst Report?
Global Health Limited (GLH) AI Stock Analysis
Global Health Limited
(ASX:GLH)
Poor financial performance is the primary driver of the low score, with weak technicals and stretched valuation adding further pressure.
Global Health Limited (GLH) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 3.31M
- Dividend Yield
- ―
- Average Volume (3M)
- 20.50K
- Price to Earnings (P/E)
- 61.4
- Beta (1Y)
- 0.15
- Revenue Growth
- -1.84%
- EPS Growth
- 13.42%
- Country
- Australia
- Employees
- 49
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Global Health Limited Business Overview & Revenue Model
Company Description
Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including specia...
Global Health Limited Financial Statement Overview
Summary
Volatile revenue, negative margins, deeply negative equity, and continued cash burn point to significant financial risks despite modest cash flow improvements.
Income Statement
25NegativeBalance Sheet
12Very NegativeCash Flow
35Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.18M | 7.18M | 8.67M | 8.12M | 7.82M | 6.54M |
| Gross Profit | -566.57K | -566.58K | 2.10M | -689.94K | -2.18M | -664.00K |
| EBITDA | -1.39M | -1.39M | -793.08K | -1.77M | -7.19M | -1.69M |
| Net Income | -758.22K | -758.22K | -866.63K | -1.31M | -8.05M | -2.05M |
Balance Sheet | ||||||
| Total Assets | 1.98M | 1.98M | 2.84M | 3.08M | 3.12M | 11.03M |
| Cash, Cash Equivalents and Short-Term Investments | 738.07K | 738.07K | 1.38M | 2.07M | 2.24M | 6.38M |
| Total Debt | 1.63M | 1.63M | 1.46M | 1.03M | 44.94K | 141.83K |
| Total Liabilities | 6.43M | 6.43M | 6.58M | 5.98M | 4.74M | 4.95M |
| Stockholders Equity | -4.45M | -4.45M | -3.73M | -2.90M | -1.62M | 6.09M |
Cash Flow | ||||||
| Free Cash Flow | -207.03K | -207.03K | -706.63K | -1.15M | -4.36M | -2.08M |
| Operating Cash Flow | -196.27K | -196.27K | -706.63K | -1.13M | -3.46M | -1.18M |
| Investing Cash Flow | -10.76K | -10.76K | 5,000 | -17.48K | -902.77K | -778.93K |
| Financing Cash Flow | -424.65K | -424.65K | -10.70K | 982.56K | 240.86K | 3.50M |
Global Health Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:GLH, the sentiment is Positive. The current price of 0.06 is below the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.06, and below the 200-day MA of 0.06, indicating a neutral trend. The MACD of 0.00 indicates Positive momentum. The RSI at 68.98 is Neutral, neither overbought nor oversold. The STOCH value of 68.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:GLH.
Global Health Limited Peers Comparison
Overall Rating
AU:RHC58Neutral
AU:REG55Neutral
AU:EPN47Neutral
AU:PGC43Neutral
AU:FCG41Neutral- AU:GLH38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:RHC | 58Neutral | AUD 12.77B | 40.88 | 6.58% | 1.64% | 4.36% | 4799.64% |
| AU:REG | 55Neutral | AUD 1.45B | 26.00 | -264.68% | 3.83% | 16.55% | 13.42% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| AU:EPN | 47Neutral | AUD 7.78M | 66.67 | 3.34% | ― | 121.40% | ― |
| AU:PGC | 43Neutral | AUD 256.57M | -16.14 | -5.34% | ― | 1.84% | -178.23% |
| AU:FCG | 41Neutral | AUD 4.01M | -10.21 | -41.70% | ― | -97.98% | 91.33% |
| AU:GLH | 38Underperform | AUD 3.25M | 61.37 | 14.48% | ― | -1.84% | 13.42% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:GLH | Global Health Limited | 0.06 | -0.05 | -47.62% | |
| AU:EPN | Epsilon Healthcare Limited | 0.02 | -0.00 | -16.67% | |
| AU:RHC | Ramsay Health Care Limited | 55.60 | 24.80 | 80.51% | |
| AU:PGC | Paragon Care Limited | 0.15 | -0.17 | -51.56% | |
| AU:REG | Regis Healthcare Ltd. | 4.80 | -2.42 | -33.54% | |
| AU:FCG | Freedom Care Group Holdings Limited | 0.04 | 0.00 | 0.00% |
Global Health Limited Corporate Events
Global Health Reshapes Company Secretarial Team to Bolster ASX Compliance
Global Health Limited has announced a change in its corporate governance team, with Christopher Fernandes resigning as Joint Company Secretary and Lachlan Morley stepping into the role alongside continuing Joint Company Secretary Anara Malabekova. Mo...
Global Health Cuts Costs and Improves Cashflow on AI-Driven Efficiency
Global Health Limited reported a marked improvement in cash metrics for the quarter and 12 months to 30 September 2026, highlighted by a 22% reduction in quarterly operating cash outflow and strong cash receipts of over $1.6 million in October, leavi...
Global Health boosts SaaS revenue and trims costs in FY2026 upgrade
Global Health Limited reported full-year FY2026 results showing a strategic shift toward higher-quality recurring revenue and improved profitability metrics despite remaining loss-making. Core annual recurring revenue, including expansion revenue, ro...
Global Health Limited Strengthens Corporate Governance Framework
Global Health Limited has detailed a comprehensive corporate governance framework that emphasises ethical standards, clear values and diversity across its organisation. The board’s composition and responsibilities are formally defined, with dis...
Global Health Files Updated ASX Corporate Governance Statement
Global Health Limited has lodged its updated corporate governance statement and Appendix 4G with the ASX for the financial year ended 30 June 2026. The statement, current as of 27 August 2026, is hosted on the company’s website and has been app...
Global Health Loss Narrows but Going-Concern Doubts Persist
Global Health Limited reported a 1.84% decline in revenue from ordinary activities to A$7.18 million for the year ended 30 June 2026, while its net loss narrowed to A$758,220 from A$866,632 a year earlier. The company did not pay, recommend or declar...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026